Aaron J Schain1,2, Agustin Melo-Carrillo1,2, David Borsook2,3, Jaime Grutzendler4, Andrew M Strassman1,2, Rami Burstein1,2. 1. Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Boston, MA. 2. Harvard Medical School, Boston, MA. 3. Center for Pain and the Brain; Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, Boston, MA. 4. Department of Neurology, Department of Neuroscience, Yale School of Medicine, New Haven, CT.
Abstract
OBJECTIVE: Cortical spreading depression (CSD) has long been implicated in migraine attacks with aura. The process by which CSD, a cortical event that occurs within the blood-brain barrier (BBB), results in nociceptor activation outside the BBB is likely mediated by multiple molecules and cells. The objective of this study was to determine whether CSD activates immune cells inside the BBB (pia), outside the BBB (dura), or in both, and if so, when. METHODS: Investigating cellular events in the meninges shortly after CSD, we used in vivo two-photon imaging to identify changes in macrophages and dendritic cells (DCs) that reside in the pia, arachnoid, and dura and their anatomical relationship to TRPV1 axons. RESULTS: We found that activated meningeal macrophages retract their processes and become circular, and that activated meningeal DCs stop migrating. We found that CSD activates pial macrophages instantaneously, pial, subarachnoid, and dural DCs 6-12 minutes later, and dural macrophages 20 minutes later. Dural macrophages and DCs can appear in close proximity to TRPV1-positive axons. INTERPRETATION: The findings suggest that activation of pial macrophages may be more relevant to cases where aura and migraine begin simultaneously, that activation of dural macrophages may be more relevant to cases where headache begins 20 to 30 minutes after aura, and that activation of dural macrophages may be mediated by activation of migratory DCs in the subarachnoid space and dura. The anatomical relationship between TRPV1-positive meningeal nociceptors, and dural macrophages and DCs supports a role for these immune cells in the modulation of head pain. Ann Neurol 2018;83:508-521.
OBJECTIVE: Cortical spreading depression (CSD) has long been implicated in migraine attacks with aura. The process by which CSD, a cortical event that occurs within the blood-brain barrier (BBB), results in nociceptor activation outside the BBB is likely mediated by multiple molecules and cells. The objective of this study was to determine whether CSD activates immune cells inside the BBB (pia), outside the BBB (dura), or in both, and if so, when. METHODS: Investigating cellular events in the meninges shortly after CSD, we used in vivo two-photon imaging to identify changes in macrophages and dendritic cells (DCs) that reside in the pia, arachnoid, and dura and their anatomical relationship to TRPV1 axons. RESULTS: We found that activated meningeal macrophages retract their processes and become circular, and that activated meningeal DCs stop migrating. We found that CSD activates pial macrophages instantaneously, pial, subarachnoid, and dural DCs 6-12 minutes later, and dural macrophages 20 minutes later. Dural macrophages and DCs can appear in close proximity to TRPV1-positive axons. INTERPRETATION: The findings suggest that activation of pial macrophages may be more relevant to cases where aura and migraine begin simultaneously, that activation of dural macrophages may be more relevant to cases where headache begins 20 to 30 minutes after aura, and that activation of dural macrophages may be mediated by activation of migratory DCs in the subarachnoid space and dura. The anatomical relationship between TRPV1-positive meningeal nociceptors, and dural macrophages and DCs supports a role for these immune cells in the modulation of head pain. Ann Neurol 2018;83:508-521.
Authors: Daphne Y S Vogel; Judith E Glim; Andrea W D Stavenuiter; Marjolein Breur; Priscilla Heijnen; Sandra Amor; Christine D Dijkstra; Robert H J Beelen Journal: Immunobiology Date: 2014-05-28 Impact factor: 3.144
Authors: Jakob M Hansen; Richard B Lipton; David W Dodick; Stephen D Silberstein; Joel R Saper; Sheena K Aurora; Peter J Goadsby; Andrew Charles Journal: Neurology Date: 2012-10-31 Impact factor: 9.910
Authors: Elly J F Vereyken; Priscilla D A M Heijnen; Wia Baron; Elga H E de Vries; Christine D Dijkstra; Charlotte E Teunissen Journal: J Neuroinflammation Date: 2011-05-26 Impact factor: 8.322
Authors: Anna P Andreou; Philip R Holland; Simon Akerman; Oliver Summ; Joe Fredrick; Peter J Goadsby Journal: Brain Date: 2016-05-30 Impact factor: 13.501
Authors: Nouchine Hadjikhani; Daniel S Albrecht; Caterina Mainero; Eri Ichijo; Noreen Ward; Cristina Granziera; Nicole R Zürcher; Oluwaseun Akeju; Guillaume Bonnier; Julie Price; Jacob M Hooker; Vitaly Napadow; Matthias Nahrendorf; Marco L Loggia; Michael A Moskowitz Journal: Ann Neurol Date: 2020-04-22 Impact factor: 10.422
Authors: Prisca R Bauer; Else A Tolner; Mark R Keezer; Michel D Ferrari; Josemir W Sander Journal: Nat Rev Neurol Date: 2021-07-26 Impact factor: 42.937